{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:45:26Z","timestamp":1794527126643,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00296-019-04506-2","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T08:03:02Z","timestamp":1578038582000},"page":"849-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-5969","authenticated-orcid":false,"given":"Ilke","family":"Coskun Benlidayi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"4506_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10067-018-4310-0","volume":"38","author":"P Muilu","year":"2019","unstructured":"Muilu P, Rantalaiho V, Kautiainen H, Virta LJ, Eriksson JG, Puolakka K (2019) Increasing incidence and shifting profile of idiopathic inflammatory rheumatic diseases in adults during this millennium. Clin Rheumatol 38:555\u2013562. https:\/\/doi.org\/10.1007\/s10067-018-4310-0","journal-title":"Clin Rheumatol"},{"key":"4506_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/13651501.2018.1492728","volume":"23","author":"I Coskun Benlidayi","year":"2019","unstructured":"Coskun Benlidayi I, Gokcen N, Sariyildiz A, Sarpel T (2019) They have got the blues: patient's mood- and disease activity-related psychological burden of rheumatoid arthritis on caregivers. Int J Psychiatry Clin Pract 23:84\u201389. https:\/\/doi.org\/10.1080\/13651501.2018.1492728","journal-title":"Int J Psychiatry Clin Pract"},{"key":"4506_CR3","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/rheumatology\/key224","volume":"57","author":"MJ Cook","year":"2018","unstructured":"Cook MJ, Bellou E, Bowes J, Sergeant JC, O\u2019Neill TW, Barton A, Verstappen SMM (2018) The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank. Rheumatology (Oxford) 57:2172\u20132182. https:\/\/doi.org\/10.1093\/rheumatology\/key224","journal-title":"Rheumatology (Oxford)"},{"key":"4506_CR4","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00296-018-4155-5","volume":"38","author":"I Coskun Benlidayi","year":"2018","unstructured":"Coskun Benlidayi I (2018) Sleep impairment: an obstacle to achieve optimal quality of life in rheumatoid arthritis. Rheumatol Int 38:2183\u20132192. https:\/\/doi.org\/10.1007\/s00296-018-4155-5","journal-title":"Rheumatol Int"},{"key":"4506_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2296-14-199","volume":"14","author":"J Ursum","year":"2013","unstructured":"Ursum J, Nielen MM, Twisk JW, Peters MJ, Schellevis FG, Nurmohamed MT, Korevaar JC (2013) Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study. BMC Family Pract 14:199","journal-title":"BMC Family Pract"},{"key":"4506_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1124\/jpet.115.230060","volume":"356","author":"I Tsilioni","year":"2016","unstructured":"Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC (2016) Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J Pharmacol Exp Ther 356:664\u2013672. https:\/\/doi.org\/10.1124\/jpet.115.230060","journal-title":"J Pharmacol Exp Ther"},{"key":"4506_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/JPR.S128508","volume":"10","author":"E B\u00e4ckryd","year":"2017","unstructured":"B\u00e4ckryd E, Tanum L, Lind AL, Larsson A, Gordh T (2017) Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res 10:515\u2013525. https:\/\/doi.org\/10.2147\/JPR.S128508","journal-title":"J Pain Res"},{"key":"4506_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","volume":"77","author":"A Molt\u00f3","year":"2018","unstructured":"Molt\u00f3 A, Etcheto A, Gossec L, Boudersa N, Claudepierre P, Roux N, Lemeunier L, Martin A, Sparsa L, Coquerelle P, Soubrier M, Perrot S, Dougados M (2018) Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study. Ann Rheum Dis 77:533\u2013540. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212378","journal-title":"Ann Rheum Dis"},{"key":"4506_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","volume":"18","author":"N Bello","year":"2016","unstructured":"Bello N, Etcheto A, B\u00e9al C, Dougados M, Molt\u00f3 A (2016) Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther 18:42. https:\/\/doi.org\/10.1186\/s13075-016-0943-z","journal-title":"Arthritis Res Ther"},{"key":"4506_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.rbre.2017.01.004","volume":"57","author":"RMDS Chakr","year":"2017","unstructured":"Chakr RMDS, Brenol C, Ranzolin A, Bernardes A, Dalosto AP, Ferrari G, Scalco S, Olszewski V, Kohem C, Monticielo O, Brenol JCT, Xavier RM (2017) Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia. Rev Bras Reumatol Engl Ed 57:403\u2013411. https:\/\/doi.org\/10.1016\/j.rbre.2017.01.004","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"4506_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4506_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","volume":"39","author":"JC Branco","year":"2010","unstructured":"Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caub\u00e8re JP, Le Lay K, Taieb C, Matucci-Cerinic M (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448\u2013453. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.12.003","journal-title":"Semin Arthritis Rheum"},{"key":"4506_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/art.38905","volume":"67","author":"GT Jones","year":"2015","unstructured":"Jones GT, Atzeni F, Beasley M, Fl\u00fc\u00df E, Sarzi-Puttini P, Macfarlane GJ (2015) The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol 67:568\u2013575. https:\/\/doi.org\/10.1002\/art.38905","journal-title":"Arthritis Rheumatol"},{"key":"4506_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.semarthrit.2017.01.005","volume":"47","author":"A Fan","year":"2017","unstructured":"Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Mathieu S, Couderc M, Soubrier M, Dubost JJ (2017) Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum 47:129\u2013132. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.01.005","journal-title":"Semin Arthritis Rheum"},{"key":"4506_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41927-019-0066-7","volume":"3","author":"GJ Macfarlane","year":"2019","unstructured":"Macfarlane GJ, Pathan E, Siebert S, Packham J, Gaffney K, Choy E, Sengupta R, Atzeni F, Martin KR, Jones GT, Dean LE (2019) AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS). BMC Rheumatol 3:19. https:\/\/doi.org\/10.1186\/s41927-019-0066-7","journal-title":"BMC Rheumatol"},{"key":"4506_CR16","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/key206","volume":"57","author":"GJ Macfarlane","year":"2018","unstructured":"Macfarlane GJ, MacDonald RIR, Pathan E, Siebert S, Gaffney K, Choy E, Packham J, Martin KR, Haywood K, Sengupta R, Atzeni F, Jones GT (2018) Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register. Rheumatology (Oxford) 57:1982\u20131990. https:\/\/doi.org\/10.1093\/rheumatology\/key206","journal-title":"Rheumatology (Oxford)"},{"key":"4506_CR17","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/art.40185","volume":"69","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Barnish MS, Pathan E, Martin KR, Haywood KL, Siebert S, Packham J, Atzeni F, Jones GT (2017) Co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK National Register. Arthritis Rheumatol 69:2144\u20132150. https:\/\/doi.org\/10.1002\/art.40185","journal-title":"Arthritis Rheumatol"},{"key":"4506_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/03009742.2015.1046484","volume":"45","author":"PR Lage-Hansen","year":"2016","unstructured":"Lage-Hansen PR, Chrysidis S, Lage-Hansen M, Hougaard A, Ejstrup L, Amris K (2016) Concomitant fibromyalgia in rheumatoid arthritis is associated with the more frequent use of biological therapy: a cross-sectional study. Scand J Rheumatol 45:45\u201348. https:\/\/doi.org\/10.3109\/03009742.2015.1046484","journal-title":"Scand J Rheumatol"},{"key":"4506_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/1756-185X.12426","volume":"19","author":"TA Gheita","year":"2016","unstructured":"Gheita TA, Sayed S, Gheita HA, Kenawy SA (2016) Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. Int J Rheum Dis 19:294\u2013299. https:\/\/doi.org\/10.1111\/1756-185X.12426","journal-title":"Int J Rheum Dis"},{"key":"4506_CR20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/1756-185X.13320","volume":"21","author":"SJ Moon","year":"2018","unstructured":"Moon SJ, Kang KY, Kwok SK, Ju JH, Hong YS, Park SH, Jeon CH, Choi ST, Song JS, Min JK (2018) Differences in quality of life determinants according to the presence of fibromyalgia in middle-aged female patients with systemic lupus erythematosus: a multicenter, cross-sectional, single-ethnicity cohort. Int J Rheum Dis 21:1173\u20131184. https:\/\/doi.org\/10.1111\/1756-185X.13320","journal-title":"Int J Rheum Dis"},{"issue":"2 Suppl 96","key":"4506_CR21","first-page":"S9","volume":"34","author":"BY Choi","year":"2016","unstructured":"Choi BY, Oh HJ, Lee YJ, Song YW (2016) Prevalence and clinical impact of fibromyalgia in patients with primary Sj\u00f6gren's syndrome. Clin Exp Rheumatol 34(2 Suppl 96):S9\u201313","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 105","key":"4506_CR22","first-page":"35","volume":"35","author":"S Perrot","year":"2017","unstructured":"Perrot S, Peixoto M, Dieud\u00e9 P, Hachulla E, Avouac J, Ottaviani S, Allanore Y (2017) Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria. Clin Exp Rheumatol 35(Suppl 105):35\u201342","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 105","key":"4506_CR23","first-page":"28","volume":"35","author":"V Torrente-Segarra","year":"2017","unstructured":"Torrente-Segarra V, Corominas H, S\u00e1nchez-Piedra C, Fern\u00e1ndez-Castro M, Andreu JL, Mart\u00ednez-Taboada VM, Oliv\u00e9 A, Rosas J, S\u00e1nchez-Alonso F, SJOGRENSER Study Group of the Spanish Society of Rheumatology (2017) Fibromyalgia prevalence and associated factors in primary Sj\u00f6gren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER). Clin Exp Rheumatol 35(Suppl 105):28\u201334","journal-title":"Clin Exp Rheumatol"},{"issue":"2 Suppl 96","key":"4506_CR24","first-page":"S40","volume":"34","author":"V Torrente-Segarra","year":"2016","unstructured":"Torrente-Segarra V, Salman-Monte TC, R\u00faa-Figueroa \u00cd, P\u00e9rez-Vicente S, L\u00f3pez-Longo FJ, Galindo-Izquierdo M, Calvo-Al\u00e9n J, Oliv\u00e9-Marqu\u00e9s A, Iba\u00f1ez-Ru\u00e1n J, Horcada L, S\u00e1nchez-Atrio A, Montilla C, Rodr\u00edguez-G\u00f3mez M, D\u00edez-\u00c1lvarez E, Martinez-Taboada V, Andreu JL, Fern\u00e1ndez-Berrizbeitia O, Hern\u00e1ndez-Beriain JA, Gantes M, Hern\u00e1ndez-Cruz B, Pecond\u00f3n-Espa\u00f1ol \u00c1, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER); Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER) (2016) Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. Clin Exp Rheumatol 34(2 Suppl 96):S40\u2013S47","journal-title":"Clin Exp Rheumatol"},{"key":"4506_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","volume":"34","author":"S Haliloglu","year":"2014","unstructured":"Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A (2014) Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 34:1275\u20131280. https:\/\/doi.org\/10.1007\/s00296-014-2972-8","journal-title":"Rheumatol Int"},{"key":"4506_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5606\/tftrd.2017.291","volume":"63","author":"M Toprak","year":"2017","unstructured":"Toprak M, Erden M, Alpayc\u0131 M, Ediz L, Yazmalar L, H\u0131z \u00d6, Tekeo\u011flu \u0130 (2017) The frequency and effect of fibromyalgia in patients with Beh\u00e7et's disease. Turk J Phys Med Rehabil 63:160\u2013164. https:\/\/doi.org\/10.5606\/tftrd.2017.291","journal-title":"Turk J Phys Med Rehabil"},{"key":"4506_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.reuma.2017.02.008","volume":"14","author":"MS El-Rabbat","year":"2018","unstructured":"El-Rabbat MS, Mahmoud NK, Gheita TA (2018) Clinical significance of fibromyalgia syndrome in different rheumatic diseases: Relation to disease activity and quality of life. Reumatol Clin 14:285\u2013289. https:\/\/doi.org\/10.1016\/j.reuma.2017.02.008","journal-title":"Reumatol Clin"},{"key":"4506_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/ced.12504","volume":"40","author":"D Graceffa","year":"2015","unstructured":"Graceffa D, Maiani E, Sperduti I, Ceralli F, Bonifati C (2015) Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasis. Clin Exp Dermatol 40:136\u2013141. https:\/\/doi.org\/10.1111\/ced.12504","journal-title":"Clin Exp Dermatol"},{"key":"4506_CR29","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3899\/jrheum.160104","volume":"43","author":"J Wach","year":"2016","unstructured":"Wach J, Letroublon MC, Coury F, Tebib JG (2016) Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol 43:2056\u20132063","journal-title":"J Rheumatol"},{"key":"4506_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00296-018-4200-4","volume":"39","author":"D Santos-Faria","year":"2019","unstructured":"Santos-Faria D, Dougados M, Gossec L, Perrot S, Molt\u00f3 A (2019) Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis. Rheumatol Int 39:141\u2013146. https:\/\/doi.org\/10.1007\/s00296-018-4200-4","journal-title":"Rheumatol Int"},{"issue":"3","key":"4506_CR31","doi-asserted-by":"publisher","first-page":"e000588","DOI":"10.1136\/rmdopen-2017-000588","volume":"28","author":"K Shah","year":"2017","unstructured":"Shah K, Paris M, Mellars L, Changolkar A, Mease PJ (2017) Real-world burden of comorbidities in US patients with psoriatic arthritis. RMD Open 28(3):e000588. https:\/\/doi.org\/10.1136\/rmdopen-2017-000588","journal-title":"RMD Open"},{"key":"4506_CR32","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3899\/jrheum.151491","volume":"43","author":"S Brikman","year":"2016","unstructured":"Brikman S, Furer V, Wollman J, Borok S, Matz H, Polachek A, Elalouf O, Sharabi A, Kaufman I, Paran D, Elkayam O (2016) The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study. J Rheumatol 43:1749\u20131754. https:\/\/doi.org\/10.3899\/jrheum.151491","journal-title":"J Rheumatol"},{"key":"4506_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13075-015-0525-5","volume":"17","author":"N Joharatnam","year":"2015","unstructured":"Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA (2015) A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther 17:11. https:\/\/doi.org\/10.1186\/s13075-015-0525-5","journal-title":"Arthritis Res Ther"},{"key":"4506_CR34","doi-asserted-by":"publisher","first-page":"e0203755","DOI":"10.1371\/journal.pone.0203755","volume":"13","author":"F Wolfe","year":"2018","unstructured":"Wolfe F, Walitt B, Perrot S, Rasker JJ, H\u00e4user W (2018) Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PLoS ONE 13:e0203755. https:\/\/doi.org\/10.1371\/journal.pone.0203755","journal-title":"PLoS ONE"},{"key":"4506_CR35","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00296-018-4096-z","volume":"38","author":"F Salaffi","year":"2018","unstructured":"Salaffi F, Di Carlo M, Carotti M, Sarzi-Puttini P (2018) The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia. Rheumatol Int 38:1911\u20131918. https:\/\/doi.org\/10.1007\/s00296-018-4096-z","journal-title":"Rheumatol Int"},{"key":"4506_CR36","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00296-017-3792-4","volume":"37","author":"F Salaffi","year":"2017","unstructured":"Salaffi F, Gerardi MC, Atzeni F, Batticciotto A, Talotta R, Draghessi A, Di Carlo M, Sarzi-Puttini P (2017) The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis. Rheumatol Int 37:2035\u20132042. https:\/\/doi.org\/10.1007\/s00296-017-3792-4","journal-title":"Rheumatol Int"},{"key":"4506_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/1756-185X.13055","volume":"21","author":"AC Gist","year":"2018","unstructured":"Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO (2018) Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis 21:639\u2013646. https:\/\/doi.org\/10.1111\/1756-185X.13055","journal-title":"Int J Rheum Dis"},{"key":"4506_CR38","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00296-015-3278-1","volume":"35","author":"J Ahmad","year":"2015","unstructured":"Ahmad J, Blumen H, Tagoe CE (2015) Association of antithyroid peroxidase antibody with fibromyalgia in rheumatoid arthritis. Rheumatol Int 35:1415\u20131421. https:\/\/doi.org\/10.1007\/s00296-015-3278-1","journal-title":"Rheumatol Int"},{"key":"4506_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5606\/tftrd.2018.1618","volume":"64","author":"A Kilicarslan","year":"2018","unstructured":"Kilicarslan A, Yurdakul FG, Bodur H (2018) Diagnosing fibromyalgia in rheumatoid arthritis: the importance of assessing disease activity. Turk J Phys Med Rehabil 64:133\u2013139. https:\/\/doi.org\/10.5606\/tftrd.2018.1618","journal-title":"Turk J Phys Med Rehabil"},{"key":"4506_CR40","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/acr.23216","volume":"69","author":"H Kim","year":"2017","unstructured":"Kim H, Cui J, Frits M, Iannaccone C, Coblyn J, Shadick NA, Weinblatt ME, Lee YC (2017) Fibromyalgia and the prediction of two-year changes in functional status in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 69:1871\u20131877. https:\/\/doi.org\/10.1002\/acr.23216","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4506_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160\u2013172","journal-title":"Arthritis Rheum"},{"key":"4506_CR42","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600\u2013610","journal-title":"Arthritis Care Res"},{"key":"4506_CR43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, H\u00e4user W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38:1113\u20131122","journal-title":"J Rheumatol"},{"key":"4506_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, H\u00e4user W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B (2016) 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 46:319\u2013329. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.012","journal-title":"Semin Arthritis Rheum"},{"key":"4506_CR45","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/ejp.1432","volume":"23","author":"F Larrosa Pardo","year":"2019","unstructured":"Larrosa Pardo F, Bondesson E, Schelin MEC, J\u00f6ud A (2019) A diagnosis of rheumatoid arthritis, endometriosis or IBD is associated with later onset of fibromyalgia and chronic widespread pain. Eur J Pain 23:1563\u20131573. https:\/\/doi.org\/10.1002\/ejp.1432","journal-title":"Eur J Pain"},{"key":"4506_CR46","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3899\/jrheum.171411","volume":"46","author":"P Macchioni","year":"2019","unstructured":"Macchioni P, Salvarani C, Possemato N, Gutierrez M, Grassi W, Gasparini S, Perricone C, Perrotta FM, Grembiale RD, Bruno C, Tripolino C, Govoni M, Ciancio G, Farina I, Ramonda R, Frallonardo P, Desiati F, Scarpa R, Costa L, Zabotti A, De Vita S, D'Attino RM, Gualberti G, Merolla R, di Luzio PU, Aldigeri R, Marchesoni A (2019) Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: the ULISSE study. J Rheumatol 46:904\u2013911. https:\/\/doi.org\/10.3899\/jrheum.171411","journal-title":"J Rheumatol"},{"key":"4506_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13075-017-1412-z","volume":"19","author":"JR Curtis","year":"2017","unstructured":"Curtis JR, Herrem C, Ndlovu MN, O'Brien C, Yazici Y (2017) A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial. Arthritis Res Ther 19:215. https:\/\/doi.org\/10.1186\/s13075-017-1412-z","journal-title":"Arthritis Res Ther"},{"key":"4506_CR48","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3899\/jrheum.131171","volume":"41","author":"N Inanc","year":"2014","unstructured":"Inanc N, Yilmaz-Oner S, Can M, Sokka T, Direskeneli H (2014) The role of depression, anxiety, fatigue, and fibromyalgia on the evaluation of the remission status in patients with rheumatoid arthritis. J Rheumatol 41:1755\u20131760. https:\/\/doi.org\/10.3899\/jrheum.131171","journal-title":"J Rheumatol"},{"issue":"Suppl 116","key":"4506_CR49","first-page":"58","volume":"37","author":"SA Provan","year":"2019","unstructured":"Provan SA, Austad C, Halsaa V, Hammer HB, Kvien TK, Uhlig T (2019) Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register. Clin Exp Rheumatol 37(Suppl 116):58\u201362","journal-title":"Clin Exp Rheumatol"},{"key":"4506_CR50","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00296-018-4138-6","volume":"38","author":"I Coskun Benlidayi","year":"2018","unstructured":"Coskun Benlidayi I (2018) Fibromyalgia as a challenge for patients and physicians. Rheumatol Int 38:2345. https:\/\/doi.org\/10.1007\/s00296-018-4138-6","journal-title":"Rheumatol Int"},{"key":"4506_CR51","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.40451","volume":"70","author":"N Basu","year":"2018","unstructured":"Basu N, Kaplan CM, Ichesco E, Larkin T, Harris RE, Murray A, Waiter G, Clauw DJ (2018) Neurobiologic features of fibromyalgia are also present among rheumatoid arthritis patients. Arthritis Rheumatol 70:1000\u20131007","journal-title":"Arthritis Rheumatol"},{"key":"4506_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejr.2017.09.002","volume":"40","author":"O Ragab","year":"2017","unstructured":"Ragab O, Khairy N, Taha R, Iskander M (2017) Serum seratonin in rheumatoid arthritis patients: relation to rheumatoid factor positivity, clinical manifestations and fibromyalgia. Egypt Rheumatol 40:149\u2013153. https:\/\/doi.org\/10.1016\/j.ejr.2017.09.002","journal-title":"Egypt Rheumatol"},{"key":"4506_CR53","first-page":"600","volume":"37","author":"JM Berthelot","year":"2019","unstructured":"Berthelot JM, Bart G, Darrieutort-Lafitte C, Le Goff B, Guillot P, Gl\u00e9marec J, Maugars Y (2019) Pain catastrophising worsens RAPID3 in all rheumatologic conditions. Clin Exp Rheumatol 37:600\u2013607","journal-title":"Clin Exp Rheumatol"},{"key":"4506_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5152\/imj.2015.75436","volume":"16","author":"A Bal","year":"2015","unstructured":"Bal A, Sayiner \u00c7aglar N, \u00c7aglar Okur S, Akin T, Aytekin E, Cetin E, Pekin Dogan Y, Erdem IH, Aysar O (2015) The effect of fibromyalgia on disease activity in patients with rheumatoid arthritis. \u0130stanbul Med J 16:18\u201322. https:\/\/doi.org\/10.5152\/imj.2015.75436","journal-title":"\u0130stanbul Med J"},{"key":"4506_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5606\/tftrd.2016.81226","volume":"1","author":"Y Garip","year":"2016","unstructured":"Garip Y, G\u00fcler T, Cifci N, Dortbas F, Karci AA (2016) Impact of fibromyalgia syndrome on quality of life in patients with Beh\u00e7et\u2019s disease. Turk J Phys Med Rehab 1:45\u201350. https:\/\/doi.org\/10.5606\/tftrd.2016.81226","journal-title":"Turk J Phys Med Rehab"},{"key":"4506_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0961203317716319","volume":"27","author":"M Piga","year":"2018","unstructured":"Piga M, Congia M, Gabba A, Figus F, Floris A, Mathieu A, Cauli A (2018) Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus. Lupus 27:190\u2013198. https:\/\/doi.org\/10.1177\/0961203317716319","journal-title":"Lupus"},{"key":"4506_CR57","doi-asserted-by":"publisher","first-page":"e0170209","DOI":"10.1371\/journal.pone.0170209","volume":"12","author":"I Etchegaray-Morales","year":"2017","unstructured":"Etchegaray-Morales I, M\u00e9ndez-Mart\u00ednez S, Jim\u00e9nez-Hern\u00e1ndez C, Mendoza-Pinto C, Alonso-Garc\u00eda NE, Montiel-Jarqu\u00edn A, L\u00f3pez-Colombo A, Garc\u00eda-Villase\u00f1or A, Cardiel MH, Garc\u00eda-Carrasco M (2017) Factors associated with health-related quality of life in mexican lupus patients using the lupusQol. PLoS ONE 12:e0170209. https:\/\/doi.org\/10.1371\/journal.pone.0170209","journal-title":"PLoS ONE"},{"key":"4506_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rbr.2014.08.004","volume":"55","author":"AL de Ara\u00fajo","year":"2015","unstructured":"de Ara\u00fajo AL, Paliares IC, de Ara\u00fajo MI, Novo NF, Cadaval RA, Martinez JE (2015) The association of fibromyalgia and systemic lupus erythematosus change the presentation and severity of both diseases? Rev Bras Reumatol 55:37\u201342. https:\/\/doi.org\/10.1016\/j.rbr.2014.08.004","journal-title":"Rev Bras Reumatol"},{"issue":"2 Suppl 96","key":"4506_CR59","first-page":"120","volume":"34","author":"O Levy","year":"2016","unstructured":"Levy O, Segal R, Maslakov I, Markov A, Tishler M, Amit-Vazina M (2016) The impact of concomitant fibromyalgia on visual analogue scales of pain, fatigue and function in patients with various rheumatic disorders. Clin Exp Rheumatol 34(2 Suppl 96):120\u2013124","journal-title":"Clin Exp Rheumatol"},{"key":"4506_CR60","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/rheumatology\/38.9.878","volume":"38","author":"A Calin","year":"1999","unstructured":"Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38:878\u2013882","journal-title":"Rheumatology (Oxford)"},{"key":"4506_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fmed.2018.00290","volume":"5","author":"A Alunno","year":"2018","unstructured":"Alunno A, Carubbi F, Stones S, Gerli R, Giacomelli R, Baraliakos X (2018) The impact of fibromyalgia in spondyloarthritis: from classification criteria to outcome measures. Front Med (Lausanne) 5:290. https:\/\/doi.org\/10.3389\/fmed.2018.00290","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 105","key":"4506_CR62","first-page":"50","volume":"35","author":"M Dougados","year":"2017","unstructured":"Dougados M, Logeart I, Szumski A, Coindreau J, Jones H (2017) Evaluation of whether extremely high enthesitis or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores suggest fibromyalgia and confound the anti-TNF response in early non-radiographic axial spondyloarthritis. Clin Exp Rheumatol 35(Suppl 105):50\u201353","journal-title":"Clin Exp Rheumatol"},{"key":"4506_CR63","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 64:640\u2013647","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4506_CR64","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12891-016-1258-6","volume":"17","author":"AN Mian","year":"2016","unstructured":"Mian AN, Chaabo K, Wajed J, Subesinghe S, Gullick NJ, Kirkham B, Garrood T (2016) Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. BMC Musculoskelet Disord 17:404. https:\/\/doi.org\/10.1186\/s12891-016-1258-6","journal-title":"BMC Musculoskelet Disord"},{"issue":"5 Suppl 85","key":"4506_CR65","first-page":"S29","volume":"32","author":"OG Segurado","year":"2014","unstructured":"Segurado OG, Sasso EH (2014) Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 32(5 Suppl 85):S29\u2013S34","journal-title":"Clin Exp Rheumatol"},{"key":"4506_CR66","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/rheumatology\/kev388","volume":"55","author":"YC Lee","year":"2016","unstructured":"Lee YC, Hackett J, Frits M, Iannaccone CK, Shadick NA, Weinblatt ME, Segurado OG, Sasso EH (2016) Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia. Rheumatology (Oxford) 55:640\u2013648. https:\/\/doi.org\/10.1093\/rheumatology\/kev388","journal-title":"Rheumatology (Oxford)"},{"key":"4506_CR67","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.semarthrit.2017.07.010","volume":"47","author":"JR Curtis","year":"2018","unstructured":"Curtis JR, Greenberg JD, Harrold LR, Kremer JM, Palmer JL (2018) Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis. Semin Arthritis Rheum 47:472\u2013477. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.07.010","journal-title":"Semin Arthritis Rheum"},{"key":"4506_CR68","doi-asserted-by":"publisher","first-page":"e0118620","DOI":"10.1371\/journal.pone.0118620","volume":"10","author":"RM da Silva Chakr","year":"2015","unstructured":"da Silva Chakr RM, Brenol JC, Behar M, Mendon\u00e7a JA, Kohem CL, Monticielo OA, Brenol CV, Xavier RM (2015) Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case\u2013control study. PLoS ONE 10:e0118620. https:\/\/doi.org\/10.1371\/journal.pone.0118620","journal-title":"PLoS ONE"},{"key":"4506_CR69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.11152\/mu.2013.2066.173.ljg","volume":"17","author":"LJ Ghib","year":"2015","unstructured":"Ghib LJ, T\u0103ma\u015f MM, Damian LO, Felea I, Muntean LM, Rednic N, Rednic S (2015) The role of ultrasonography in assessing disease activity in patients with rheumatoid arthritis and associated fibromyalgia. Med Ultrason 17:339\u2013344. https:\/\/doi.org\/10.11152\/mu.2013.2066.173.ljg","journal-title":"Med Ultrason"},{"key":"4506_CR70","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00296-019-04251-6","volume":"39","author":"I Coskun Benlidayi","year":"2019","unstructured":"Coskun Benlidayi I (2019) Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int 39:781\u2013791. https:\/\/doi.org\/10.1007\/s00296-019-04251-6","journal-title":"Rheumatol Int"},{"key":"4506_CR71","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/CIA.S60330","volume":"9","author":"M Imamura","year":"2014","unstructured":"Imamura M, Targino RA, Hsing WT, Imamura S, Azevedo RS, Boas LS, Tozetto-Mendoza TR, Alfieri FM, Filippo TR, Battistella LR (2014) Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia. Clin Interv Aging 9:939\u2013944. https:\/\/doi.org\/10.2147\/CIA.S60330","journal-title":"Clin Interv Aging"},{"key":"4506_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","volume":"290","author":"D Mendieta","year":"2016","unstructured":"Mendieta D, De la Cruz-Aguilera DL, Barrera-Villalpando MI, Becerril-Villanueva E, Arreola R, Hern\u00e1ndez-Ferreira E, P\u00e9rez-Tapia SM, P\u00e9rez-S\u00e1nchez G, Garc\u00e9s-Alvarez ME, Aguirre-Cruz L, Velasco-Vel\u00e1zquez MA, Pav\u00f3n L (2016) IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. J Neuroimmunol 290:22\u201325. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.11.011","journal-title":"J Neuroimmunol"},{"key":"4506_CR73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2011.10.013","volume":"242","author":"D Kadetoff","year":"2012","unstructured":"Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E (2012) Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol 242:33\u201338. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.10.013","journal-title":"J Neuroimmunol"},{"issue":"6 Suppl 79","key":"4506_CR74","first-page":"S60","volume":"31","author":"AP Pernambuco","year":"2013","unstructured":"Pernambuco AP, Schetino LP, Alvim CC, Murad CM, Viana RS, Carvalho LS, Reis D (2013) Increased levels of IL-17A in patients with fibromyalgia. Clin Exp Rheumatol 31(6 Suppl 79):S60\u201363","journal-title":"Clin Exp Rheumatol"},{"key":"4506_CR75","doi-asserted-by":"publisher","first-page":"e0180014","DOI":"10.1371\/journal.pone.0180014","volume":"12","author":"S Rifbjerg-Madsen","year":"2017","unstructured":"Rifbjerg-Madsen S, Christensen AW, Christensen R, Hetland ML, Bliddal H, Kristensen LE, Danneskiold-Sams\u00f8e B, Amris K (2017) Pain and pain mechanisms in patients with inflammatory arthritis: a Danish nationwide cross-sectional DANBIO registry survey. PLoS ONE 12:e0180014. https:\/\/doi.org\/10.1371\/journal.pone.0180014","journal-title":"PLoS ONE"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04506-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:17:05Z","timestamp":1609546625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04506-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4506"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04506-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that she has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}